(Q34303955)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

hepatocellular carcinoma

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

G K Grünwald

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

K Klutz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

M J Willhauck

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

N Schwenk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

R Senekowitsch-Schmidtke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

C Zach

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

B Göke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

P S Holm

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

C Spitzweg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

4 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

625-633

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

cites work

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Iodide transport in the thyroid gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

The biology of the sodium iodide symporter and its potential for targeted gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

The use of molecular imaging of gene expression by radiotracers in gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Sodium Iodide Symporter (NIS)-Mediated Radionuclide (131I, 188Re) Therapy of Liver Cancer After Transcriptionally Targeted Intratumoral in Vivo NIS Gene Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

In vivo sodium iodide symporter gene therapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

In vivo imaging and tumor therapy with the sodium iodide symporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

The sodium iodide symporter: its pathophysiological and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Adenoviruses: update on structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Oncolytic (replication-competent) adenoviruses as anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Targeted radionuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na/I symporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Designer adenoviruses for nanomedicine and nanodiagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

The adenovirus E4orf6 protein inhibits DNA double strand break repair and radiosensitizes human tumor cells in an E1B-55K-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

The adenoviral E4orf6 protein induces atypical apoptosis in response to DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

ReVOLT: radiation-enhanced viral oncolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Inhibition of repair of radiation-induced DNA damage enhances gene expression from replication-defective adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: implications for sodium iodide symporter gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Dosimetric considerations in the radioiodine treatment of macrometastases and micrometastases from differentiated thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Dosimetry and thyroid cancer: the individual dosage of radioiodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Feasibility of Adenovirus-Mediated hNIS Gene Transfer and 131I Radioiodine Therapy as a Definitive Treatment for Localized Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

Genetically targeted radiotherapy for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

inferred from DOI database lookup

7 January 2021

based on heuristic

Iodide transport in a continuous line of cultured cells from rat thyroid

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.79

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2012.79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json

release_tbz73c6lxfenpieuohyrinmlq4

9 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tbz73c6lxfenpieuohyrinmlq4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23038026%20AND%20SRC:MED&resulttype=core&format=json